JP2022554094A5 - - Google Patents
Info
- Publication number
- JP2022554094A5 JP2022554094A5 JP2022523294A JP2022523294A JP2022554094A5 JP 2022554094 A5 JP2022554094 A5 JP 2022554094A5 JP 2022523294 A JP2022523294 A JP 2022523294A JP 2022523294 A JP2022523294 A JP 2022523294A JP 2022554094 A5 JP2022554094 A5 JP 2022554094A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyldiyl
- peg
- compound according
- amino
- thienoazepine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962926324P | 2019-10-25 | 2019-10-25 | |
| US62/926,324 | 2019-10-25 | ||
| PCT/US2020/057162 WO2021081402A1 (en) | 2019-10-25 | 2020-10-23 | Macromolecule-supported thienoazepine compounds, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022554094A JP2022554094A (ja) | 2022-12-28 |
| JP2022554094A5 true JP2022554094A5 (cg-RX-API-DMAC7.html) | 2023-10-20 |
Family
ID=73476237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523294A Withdrawn JP2022554094A (ja) | 2019-10-25 | 2020-10-23 | 高分子支持チエノアゼピン化合物、及びそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230257393A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4048314A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022554094A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114828894A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3154969A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021081402A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109843327B (zh) | 2016-07-07 | 2022-05-13 | 小利兰·斯坦福大学托管委员会 | 抗体佐剂缀合物 |
| WO2020190725A1 (en) | 2019-03-15 | 2020-09-24 | Bolt Biotherapeutics, Inc. | Immunoconjugates targeting her2 |
| TWI857167B (zh) | 2019-10-25 | 2024-10-01 | 美商博特生物治療公司 | 噻吩并氮呯免疫結合物及其用途 |
| IL300316A (en) * | 2020-08-13 | 2023-04-01 | Bolt Biotherapeutics Inc | Immune conjugates of pyrazolozapines and their uses |
| JP2024539993A (ja) | 2021-10-29 | 2024-10-31 | ボルト バイオセラピューティクス、インコーポレーテッド | システイン変異抗体を含むｔｌｒアゴニスト免疫複合体、及びその使用 |
| WO2026050214A1 (en) * | 2024-08-27 | 2026-03-05 | Bolt Biotherapeutics, Inc. | Anti-claudin, tlr agonist immunoconjugates and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190336615A1 (en) * | 2017-01-27 | 2019-11-07 | Silverback Therapeutics, Inc. | Tumor targeting conjugates and methods of use thereof |
| CA3100544A1 (en) * | 2018-05-17 | 2019-11-21 | Bolt Biotherapeutics, Inc. | Immunoconjugates |
| TWI857167B (zh) * | 2019-10-25 | 2024-10-01 | 美商博特生物治療公司 | 噻吩并氮呯免疫結合物及其用途 |
-
2020
- 2020-10-23 EP EP20808564.7A patent/EP4048314A1/en not_active Withdrawn
- 2020-10-23 WO PCT/US2020/057162 patent/WO2021081402A1/en not_active Ceased
- 2020-10-23 JP JP2022523294A patent/JP2022554094A/ja not_active Withdrawn
- 2020-10-23 CN CN202080086885.5A patent/CN114828894A/zh active Pending
- 2020-10-23 CA CA3154969A patent/CA3154969A1/en active Pending
- 2020-10-23 US US17/768,165 patent/US20230257393A1/en not_active Abandoned